April 6, 2022: Yahoo Finance, MarketWatch, Associated Press (AP), 345 other media outlets published a press release about Dr. Gumrukcu’s invitation to present his innovative clinical strategies to treat HIV and Cancer at the Innate Killer Summit in San Diego, California.
March 28, 2022: Do you really need a 4th COVID-19 shot? That’s what the writers at MSN News were pondering, so they reached out to experts for comment, including Seraph Research Institute founder, and infectious diseases expert, Dr. Serhat Gumrukcu, who explains, “The more the virus moves from one person to another, the more it mutates and changes, making it less responsive to the vaccine” and more.
March 22, 2022: Seraph Research Institute founder, and infectious disease expert, Dr. Serhat Gumrukcu was recently quoted in a recent article in Men’s Health regarding How Long Covid Causes Muscle Pain, and What to Do About It. In the article, Dr Gumrukcu explained how lasting symptoms after contracting the coronavirus is referred to as “Long Covid” and details some of the symptoms associated with Long Covid.
March 21, 2022: When the writers at Men’s Health were working on an article about the best face masks to wear to fend off the Omnicron variant, they contacted Seraph Research Institute founder, and infectious diseases expert, Dr. Serhat Gumrukcu, for comment.
March 15, 2022: MarketWatch, Yahoo Finance, Associated Press (AP), 226 other media outlets published a press release about founder and executive director of Seraph Research Institute and co- founder and inventor of Enochian BioSciences entering a partnership with Caring Cross to improve the effectiveness of a potential cure for HIV with an anti-HIV CAR-T therapy that Caring Cross is studying in a clinical trial.
January 26, 2022: Yahoo! Life ran an article that featured COVID prevention recommendations from Seraph Research Institute founder, Dr. Serhat Gumrukcu. The article titled, 6 Safest Things to do Right Now, During Omicron, reached over 3.6 billion readers.
January 12, 2022: Infectious disease expert and pioneering scientific researcher, Seraph Research Institute founder, Dr. Serhat Gumrukcu, was quoted in a recent MarketWatch article titled, “Doctors reveal the best face masks to protect kids from the omicron coronavirus variant.”
December 25, 2021: Yahoo Life ran an article that featured Dr. Gumrukcu explaining the constant spike in the number of Omicron positive cases. The article titled, Most People Catch COVID This Way, Science Says, which reached over 3.6 billion readers.
December 15, 2021: Listen to Fancy Labcoat Guild hosts Guy Rohkin and Ali Dashti interview Dr. Gumrukcu in an eposide titled “Science is an art–not an equation with Dr. Serhat Gumrukcu.” The Fancy Labcoat guild is a space where scientists share their insights about their life, their life’s work, and the scientific zeitgeist.
December 13, 2021: Dr. Serhat Gumrukcu, is the founder and executive director of Seraph Research Institute and co- founder and inventor of Enochian BioSciences. In this CBSN interview, CEO of Enochian BioSciences, Mark Dybul, discusses the prediction of vaccine-resistant strains of COVID-19 developing in the future with CBSN’s “Red & Blue” anchor Elaine Quijano.
December 11, 2021: When the health writers at Eat This, Not That! wanted to get some opinions about the future of the COVID pandemic, they reached out to Dr. Gumrukcu and other infectious disease experts for their insights. In the article, Virus Expert Just Predicted When Pandemic Will End, Dr. Gumrukcu shares something that must be done immediately to make people less susceptible to other COVID-19 variants as they emerge.
January 12, 2022: When the health writers at Eat This, Not That! wanted infectious disease experts to comment on The #1 Worst Place You Could Go Right Now, Say Virus Experts, they started with Seraph Research founder, Dr. Serhat Gumrukcu. In the article, which was later picked up by Yahoo News, Dr. Gumrukcu speaks about the risks of contracted the coronavirus amongst the vaccinated.
December 21, 2021: “Unless we change our approach now, we seem doomed to repeated cycles of partial vaccine coverage – followed by new variants and economic devastation. Governments will not solve the problem.” Click on the article to read the commentary in Fortune.com by Mark Dybul, CEO of Enochian BioSciences and Dr. Serhat Gumrukcu, founder and executive director of Seraph Research Institute and co-founder and inventor of Enochian BioSciences.
November 22, 2021: Beating COVID Will Require a 5-Part Strategy—Including Mandatory Boosters and a Drug We Don’t Have Yet, appeared in Fortune. The commentary piece was written by Mark Dybul, CEO of Enochian BioSciences and Dr. Serhat Gumrukcu, founder and executive director of Seraph Research Institute and co-founder and inventor of Enochian BioSciences. The piece was also picked up by Fortune China.
October 6, 2021: When the health writers at Best Life wanted to know what signs to look for to avoid contracting COVID-19 when dining out, they turned to infectious disease expert and research scientist, Dr. Serhat Gumrukcu, for comment.
October 19, 2021: Associated Press (AP), MarketWatch, Yahoo Finance, Globe & Mail and over 120 other media outlets published a press release about Dr. Gumrukcu’s pioneering HIV cell therapy approach successfully completing the FDA Pre-investigational new drug (Pre-IND) stage, bringing the treatment another critical step closer to offering a cure for people living with HIV.
June 15, 2021: Associated Press (AP), MarketWatch, The New York Times, CNBC and over 115 other media outlets published a press release about Dr. Serhat’s pioneering HIV cell therapy approach – which which moves Seraph Research Institute one step closer to finding a cure for HIV.
May 12, 2021: Associated Press (AP), MarketWatch, The Globe & Mail and over 109 other other media outlets published a press release about Dr. Serhat’s promising new HIV cell therapy approach – which was presented at the 2021 Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), and very well received by thousands of industry attendees.
March 24, 2021: Yahoo Finance, MarketWatch and Associated Press (AP), as well as 91 other media outlets published a press release about Dr. Serhat’s case study that was published in the American Journal of Case Reports, complete remission for a period of 15 months in a patient with recurrent glioblastoma.
Hijacking HBV Pol to Selectively Induce Apoptosis in Infected Hepatocytes In Vivo: A Novel Approach for Potential Treatment...
Glutamate-Cysteine Ligase Modifier Subunit Overexpression Confers Resistance Against Busulfan Conference: ASGCT 23rd Annual...
Important Role of gd T Cells in Anti-SARS-CoV-2 Immune Response Citation Preview Gumrukcu, Serhat & Singh, Spriha &...
For research updates and news, please enter your email address in the field below.
©2022 | Seraph Research Institute
INDIVIDUALIZED RESEARCH | DISCLOSURE
